Sirtex: Interim result 2016

Sirtex had another strong half and improving Government reimbursement should make for a strong year ahead.

After 45 consecutive quarters of growth, it comes as little surprise that Sirtex Medical has posted a 46th.

Sales of the company’s internal radiotherapy for liver cancer, a product known as SIR-Spheres, increased 16% to 5,728 doses for the six months to December.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles